LOS ANGELES (PRWEB)
July 12, 2023

MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market, today announced that IQVIA™ (NYSE:IQV) Technology’s SmartSolve® platform was selected as a winner in the 7th annual MedTech Breakthrough Awards program, winning the “Best New Technology Solution for Drug Development” award.

“SmartSolve enables organizations to drive continuous improvement in quality across global operations, and increase focus on ‘go-to-market, grow-in-market, stay-in-market’ organizational priorities,” said Joe Rymsza, Vice President, Global Safety, Regulatory and Quality Technology Solutions of IQVIA. “It helps eliminate siloed systems and enables informed, data-driven decision making in response to global demands.”

As part of IQVIA’s suite of purpose-built safety, regulatory and quality technologies, and services, SmartSolve is a complete enterprise quality management system (eQMS). AI algorithms using machine learning (ML) and natural language processing (NLP) simplify quality compliance operation and management. Integration of regulatory intelligence and research ensure that users stay current with regulations and sophisticated quality compliance requirements.

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work, and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year’s program attracted more than 4,000 nominations from over 17 different countries throughout the world.

“MedTech quality decision-makers are constantly challenged to build a commercially focused ‘quality culture’, manage complex processes and resources on tight deadlines, and ensure compliance in a rapidly changing global environment,” said James Johnson, managing director, MedTech Breakthrough. “SmartSolve represents a true breakthrough in eQMS, offering the most comprehensive closed-loop process integration available. Organizations can achieve regulatory compliance while maintaining continuous improvement with this platform. Together with IQVIA Vigilance Platform and RIM Smart regulatory management, it is a true powerhouse of connected intelligence. Congratulations to the IQVIA team on a well-deserved 2023.”

####

About MedTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services, and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity, and more.

For more information visit MedTechBreakthrough.com.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources, and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures.

To learn more, visit iqvia.com.

Share article on social media or email: